Indeed, the number of BCR-ABL copies and transcript levels were found to be significantly higher within CD34+38− CML cells suggesting an increased activity of the BCR-ABL protein in this cell subpopulation [22]. Here, CD34 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.